Drew Moghanaki, Professor, Chief of Thoracic Oncology at the Department of Radiation Oncology and Stanley Iezman and Nancy Stark Endowed Chair in Thoracic Radiation Oncology Research at David Geffen School of Medicine at UCLA, and Chief Medical Officer of Respirati, shared a post on X:
“A report co-authored by single-fraction lung SBRT enthusiasts demonstrates how (not) often this treatment schedule is being used in the US.
The manuscript is currently undergoing minor revisions and will be published soon.”
Read Further: Day 1 Highlights from ASTRO 2025 by Drew Moghanaki.